The results revealed that low expression of IGFBP3 was closely correlated with advanced tumor stage (P = 0.020), involvement of >1 extranodal sites (P = 0.033), higher IPI score (P = 0.007), and elevated LDH levels (P = 0.011) (Table 2). The gene discussed is IGFBP3; the disease is neoplasm.